Join Mike Snape (CEO, AMO Pharma) and Donna Mackey (Senior Director of Clinical Operations, Alnylam) as they explore how to overcome the challenges of rare disease clinical trials – including trial design, patient recruitment and retention, and site support. Moderated by Ibs Mahmood (CEO, DrugDev) and Kris Sarajian (VP of Marketing, DrugDev)